Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Regression of Fibrosis After Direct-acting Antivirals Treatment of Patients with Hepatitis C Virus Cirrhosis: Transposability to Nondecompensated Patients.

Giannini EG, Crespi M, Demarzo M, Bodini G, Furnari M, Marabotto E, Torre F.

J Clin Exp Hepatol. 2019 Jul-Aug;9(4):546. doi: 10.1016/j.jceh.2018.10.007. Epub 2018 Nov 8. No abstract available.

PMID:
31516272
2.

Pediatric Trigeminal Schwannoma: From a "Minimally Invasive" to a Combined Endovascular and Surgical Management.

Nicoletti G, Galvano G, Ponzo G, Raciti MV, Furnari M, Riolo C, Cannella A, Iacopino DG, Scavone A, Lo Bue E, Graziano F.

World Neurosurg. 2019 Sep;129:552-554. doi: 10.1016/j.wneu.2019.05.079. No abstract available.

PMID:
31426264
3.

Outcome of Cytomegalovirus Colitis in Inflammatory Bowel Disease with Different Regimes of Ganciclovir.

Ahmed I, Kassem W, Salam Y, Furnari M, Mehta T.

Middle East J Dig Dis. 2018 Oct;10(4):220-229. doi: 10.15171/mejdd.2018.114. Epub 2018 Sep 5.

4.

Advancements in the use of manometry and impedance testing for esophageal functional disorders.

Savarino E, Marabotto E, Bodini G, Furnari M, Della Coletta M, Ghisa M, Barberio B, Frazzoni M, De Bortoli N, Zentilin P, Pellegatta G, Tolone S, Ottonello A, Savarino V.

Expert Rev Gastroenterol Hepatol. 2019 May;13(5):425-435. doi: 10.1080/17474124.2019.1595587. Epub 2019 Mar 21.

PMID:
30896306
5.

Erector spinae plane block combined with a novel technique for selective brachial plexus block in breast cancer surgery -a case report.

De Cassai A, Bonvicini D, Ruol M, Correale C, Furnari M.

Korean J Anesthesiol. 2019 Jun;72(3):270-274. doi: 10.4097/kja.d.18.00266. Epub 2018 Nov 27.

6.

Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals.

Giannini EG, Crespi M, Demarzo M, Bodini G, Furnari M, Marabotto E, Torre F, Zentilin P, Savarino V.

Eur J Clin Invest. 2019 Mar;49(3):e13056. doi: 10.1111/eci.13056. Epub 2018 Dec 19.

PMID:
30474209
7.

Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder.

Crist RC, Phillips KA, Furnari MA, Moran LM, Doyle GA, McNicholas LF, Cornish JW, Kampman KM, Preston KL, Berrettini WH.

Pharmacogenomics J. 2019 Jun;19(3):260-268. doi: 10.1038/s41397-018-0065-x. Epub 2018 Oct 27.

8.

Harmonising proton pump inhibitors treatment in the specialist setting following the SIGE recommendations.

Crespi M, Ghidotti I, Bodini G, Furnari M, Marabotto E, Giannini EG.

Dig Liver Dis. 2019 Jan;51(1):173-174. doi: 10.1016/j.dld.2018.09.025. Epub 2018 Oct 1. No abstract available.

PMID:
30366811
9.

Proton pump inhibitors: use and misuse in the clinical setting.

Savarino V, Marabotto E, Zentilin P, Furnari M, Bodini G, De Maria C, Pellegatta G, Coppo C, Savarino E.

Expert Rev Clin Pharmacol. 2018 Nov;11(11):1123-1134. doi: 10.1080/17512433.2018.1531703. Epub 2018 Oct 10. Review.

PMID:
30295105
10.

Effects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson's disease.

Freo U, Furnari M, Ori C.

J Pain Res. 2018 Sep 13;11:1849-1856. doi: 10.2147/JPR.S164939. eCollection 2018.

11.

The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.

Furnari M, De Alessandri A, Cresta F, Haupt M, Bassi M, Calvi A, Haupt R, Bodini G, Ahmed I, Bagnasco F, Giannini EG, Casciaro R.

J Gastroenterol. 2019 Mar;54(3):261-270. doi: 10.1007/s00535-018-1509-4. Epub 2018 Sep 19.

PMID:
30232597
12.

High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation.

Tolone S, Savarino E, Zaninotto G, Gyawali CP, Frazzoni M, de Bortoli N, Frazzoni L, Del Genio G, Bodini G, Furnari M, Savarino V, Docimo L.

United European Gastroenterol J. 2018 Aug;6(7):981-989. doi: 10.1177/2050640618769160. Epub 2018 Apr 20.

13.

NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis.

Giannini EG, Bodini G, Furnari M, Marabotto E.

J Hepatol. 2018 Oct;69(4):972-973. doi: 10.1016/j.jhep.2018.05.016. Epub 2018 Jul 4. No abstract available.

PMID:
30227919
14.

Bleeding after paracentesis in patients with decompensated cirrhosis and acute kidney injury: The perfect storm.

Giannini EG, Bodini G, Furnari M, Marabotto E.

Liver Int. 2018 Nov;38(11):2101. doi: 10.1111/liv.13962. Epub 2018 Oct 8. No abstract available.

PMID:
30223302
15.

Sniffing out causes of gastrointestinal disorders: a review of volatile metabolomic biomarkers.

Ahmed I, Niaz Z, Ewbank F, Akarca D, Felwick R, Furnari M.

Biomark Med. 2018 Oct;12(10):1139-1148. doi: 10.2217/bmm-2018-0074. Epub 2018 Sep 7. Review.

PMID:
30191735
16.

Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients.

Giannini EG, Giambruno E, Brunacci M, Plaz Torres MC, Furnari M, Bodini G, Zentilin P, Savarino V.

Ann Hepatol. 2018 Jun 5;17(5):830-835. doi: 10.5604/01.3001.0012.0775.

17.

Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder.

Schroeder JR, Phillips KA, Epstein DH, Jobes ML, Furnari MA, Kennedy AP, Heilig M, Preston KL.

Psychopharmacology (Berl). 2018 Oct;235(10):2957-2966. doi: 10.1007/s00213-018-4986-5. Epub 2018 Aug 6.

PMID:
30079432
18.

A safety review of proton pump inhibitors to treat acid-related digestive diseases.

Savarino E, Marabotto E, Zentilin P, Furnari M, Bodini G, Pellegatta G, Lorenzon G, Della Coletta M, Ghisa M, Coppo C, Marinelli C, Savarino V.

Expert Opin Drug Saf. 2018 Aug;17(8):785-794. doi: 10.1080/14740338.2018.1497155. Epub 2018 Jul 23. Review.

PMID:
30035645
19.

A Closer Look at Factors Associated With Bleeding in Cirrhotic Patients.

Giannini EG, Bodini G, Furnari M, Marabotto E.

Am J Gastroenterol. 2019 Feb;114(2):364-365. doi: 10.1038/s41395-018-0128-2. No abstract available.

PMID:
29910461
20.

Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn.

Marabotto E, Furnari M, Giannini EG, Savarino V, Savarino E.

Aliment Pharmacol Ther. 2018 Jul;48(1):107-108. doi: 10.1111/apt.14800. No abstract available.

PMID:
29882977
21.

The appropriate use of proton-pump inhibitors.

Savarino V, Marabotto E, Zentilin P, Furnari M, Bodini G, De Maria C, Pellegatta G, Coppo C, Savarino E.

Minerva Med. 2018 Oct;109(5):386-399. doi: 10.23736/S0026-4806.18.05705-1. Epub 2018 May 31. Review.

PMID:
29856192
22.

Treatment of early stage chronic hepatitis C virus infection.

Ponziani FR, Miele L, Tortora A, Furnari M, Bodini G, Pompili M, Gasbarrini A, Giannini EG.

Expert Rev Clin Pharmacol. 2018 May;11(5):519-524. doi: 10.1080/17512433.2018.1447923. Epub 2018 Mar 9. Review.

PMID:
29498556
23.

The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors.

Furnari M, Buda A, Delconte G, Citterio D, Voiosu T, Ballardini G, Cavallaro F, Savarino E, Mazzaferro V, Meroni E.

J Gastrointestin Liver Dis. 2017 Jun;26(2):151-156. doi: 10.15403/jgld.2014.1121.262.wce.

24.

Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time.

Frazzoni L, Frazzoni M, de Bortoli N, Tolone S, Furnari M, Martinucci I, Bertani H, Marchi S, Conigliaro R, Fuccio L, Savarino V, Savarino E.

Neurogastroenterol Motil. 2017 Nov;29(11). doi: 10.1111/nmo.13116. Epub 2017 May 25.

PMID:
28543861
25.

Complexity and diversity of gastroesophageal reflux disease phenotypes.

Zentilin P, Marabotto E, Pellegatta G, Coppo C, Furnari M, Savarino E, Savarino V.

Minerva Gastroenterol Dietol. 2017 Sep;63(3):198-204. doi: 10.23736/S1121-421X.17.02399-6. Epub 2017 Mar 7. Review.

PMID:
28272380
26.

Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors.

Tolone S, Gualtieri G, Savarino E, Frazzoni M, de Bortoli N, Furnari M, Casalino G, Parisi S, Savarino V, Docimo L.

World J Gastrointest Surg. 2016 Nov 27;8(11):719-728. Review.

27.

Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.

Bodini G, Giannini EG, De Maria C, Dulbecco P, Furnari M, Marabotto E, Savarino V, Savarino E.

Dig Liver Dis. 2017 Feb;49(2):175-180. doi: 10.1016/j.dld.2016.10.014. Epub 2016 Nov 2.

PMID:
27864028
28.

The natural history of gastro-esophageal reflux disease: a comprehensive review.

Savarino E, de Bortoli N, De Cassan C, Della Coletta M, Bartolo O, Furnari M, Ottonello A, Marabotto E, Bodini G, Savarino V.

Dis Esophagus. 2017 Feb 1;30(2):1-9. doi: 10.1111/dote.12511. Review.

PMID:
27862680
29.

The sensory system of the esophagus--what do we know?

Brock C, Gregersen H, Gyawali CP, Lottrup C, Furnari M, Savarino E, Novais L, Frøkjaer JB, Bor S, Drewes AM.

Ann N Y Acad Sci. 2016 Sep;1380(1):91-103. doi: 10.1111/nyas.13205. Epub 2016 Sep 6. Review.

PMID:
27598834
30.

Current treatment options for esophageal diseases.

Martínek J, Akiyama JI, Vacková Z, Furnari M, Savarino E, Weijs TJ, Valitova E, van der Horst S, Ruurda JP, Goense L, Triadafilopoulos G.

Ann N Y Acad Sci. 2016 Oct;1381(1):139-151. doi: 10.1111/nyas.13146. Epub 2016 Jul 8. Review.

PMID:
27391867
31.

Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants.

Furnari M, Savarino V, de Bortoli N, Savarino E.

Autoimmun Rev. 2016 Dec;15(12):1208-1209. doi: 10.1016/j.autrev.2016.09.025. Epub 2016 Sep 23. No abstract available.

PMID:
27666817
32.

Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool.

Furnari M, Savarino V, Savarino E.

Autoimmun Rev. 2016 Dec;15(12):1206-1207. doi: 10.1016/j.autrev.2016.09.026. Epub 2016 Sep 23. No abstract available.

PMID:
27666812
33.

Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD.

de Bortoli N, Frazzoni L, Savarino EV, Frazzoni M, Martinucci I, Jania A, Tolone S, Scagliarini M, Bellini M, Marabotto E, Furnari M, Bodini G, Russo S, Bertani L, Natali V, Fuccio L, Savarino V, Blandizzi C, Marchi S.

Am J Gastroenterol. 2016 Dec;111(12):1711-1717. doi: 10.1038/ajg.2016.432. Epub 2016 Sep 20.

PMID:
27644732
34.

The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring.

Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Furnari M, Martinucci I, Mirante VG, Marchi S, Savarino V, Savarino E.

Neurogastroenterol Motil. 2017 Mar;29(3). doi: 10.1111/nmo.12947. Epub 2016 Sep 12.

PMID:
27620303
35.

Effect of the CRF1-receptor antagonist pexacerfont on stress-induced eating and food craving.

Epstein DH, Kennedy AP, Furnari M, Heilig M, Shaham Y, Phillips KA, Preston KL.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3921-3932. Epub 2016 Sep 5.

36.

It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients.

Savarino E, Furnari M, Ottonello A, Savarino V.

Am J Gastroenterol. 2016 Sep;111(9):1364. doi: 10.1038/ajg.2016.290. No abstract available.

PMID:
27580788
37.

Microscopic Esophagitis, Baseline Impedance and Post-Reflux Swallow-Induced Peristaltic Wave in Functional Heartburn: Useful Diagnostic Tools.

Furnari M, Tolone S, de Bortoli N.

Am J Gastroenterol. 2016 Sep;111(9):1363-4. doi: 10.1038/ajg.2016.289. No abstract available.

PMID:
27580787
38.

Breath Tests to Assess Alcoholic Liver Disease.

Furnari M, Ahmed I, Erpecum KJ, Savarino V, Giannini EG.

Rev Recent Clin Trials. 2016;11(3):185-90. Review.

PMID:
27515960
39.

Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations.

Savarino E, Martinucci I, Furnari M, Romana C, Pellegatta G, Moscatelli A, Bodini G, Marabotto E, Savarino V, de Bortoli N, Blandizzi C.

Expert Opin Drug Metab Toxicol. 2016 Nov;12(11):1333-1341. doi: 10.1080/17425255.2016.1214714. Epub 2016 Aug 8.

PMID:
27428571
40.

Tryciclic Antidepressants in Refractory GERD: Poorly Effective Drugs or Wrong Patients?

Savarino E, Furnari M, Bodini G, Savarino V.

Am J Gastroenterol. 2016 Jul;111(7):1037-8. doi: 10.1038/ajg.2016.135. No abstract available.

PMID:
27356832
41.

Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn.

Frazzoni M, de Bortoli N, Frazzoni L, Furnari M, Martinucci I, Tolone S, Farioli A, Marchi S, Fuccio L, Savarino V, Savarino E.

J Gastroenterol. 2017 Apr;52(4):444-451. doi: 10.1007/s00535-016-1226-9. Epub 2016 May 30.

PMID:
27241210
42.

Barrett's esophagus in 2016: From pathophysiology to treatment.

Martinucci I, de Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A, Malecka-Panas E, Savarino V, Savarino E, Marchi S.

World J Gastrointest Pharmacol Ther. 2016 May 6;7(2):190-206. doi: 10.4292/wjgpt.v7.i2.190. Review.

43.

Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease.

Furnari M, Bodini G, Giannini EG, Savarino V.

Aliment Pharmacol Ther. 2016 Jun;43(11):1240-1. doi: 10.1111/apt.13581. No abstract available.

44.

Degree of colonic distension: intrapatient comparison between CT colonography and CT with water enema.

Revelli M, Bacigalupo L, Cevasco L, Furnari M, Paparo F, Scopelliti L, Rosenberg I, Rollandi GA.

Clin Imaging. 2016 May-Jun;40(3):425-30. doi: 10.1016/j.clinimag.2015.11.019. Epub 2015 Dec 3.

PMID:
27133680
45.

Postoperative Bilateral Brachial Plexopathy in a Diabetic Patient.

Freo U, Zara G, Furnari M, Ori C.

Pain Med. 2016 Oct;17(10):1962-1965. Epub 2016 Apr 14. No abstract available.

PMID:
27084414
46.

Lidocaine 5% Medicated Plaster for Spinal Neuropathic Pain.

Freo U, Ambrosio F, Furnari M, Ori C.

J Pain Palliat Care Pharmacother. 2016 Jun;30(2):111-3. doi: 10.3109/15360288.2016.1145780. Epub 2016 Mar 28.

PMID:
27018847
47.

Esophageal testing: What we have so far.

de Bortoli N, Martinucci I, Bertani L, Russo S, Franchi R, Furnari M, Tolone S, Bodini G, Bolognesi V, Bellini M, Savarino V, Marchi S, Savarino EV.

World J Gastrointest Pathophysiol. 2016 Feb 15;7(1):72-85. doi: 10.4291/wjgp.v7.i1.72. Review.

48.

Esophagogastric junction morphology assessment by high resolution manometry in obese patients candidate to bariatric surgery.

Tolone S, Savarino E, de Bortoli N, Frazzoni M, Furnari M, d'Alessandro A, Ruggiero R, Docimo G, Brusciano L, Gili S, Pirozzi R, Parisi S, Colella C, Bondanese M, Pascotto B, Buonomo N, Savarino V, Docimo L.

Int J Surg. 2016 Apr;28 Suppl 1:S109-13. doi: 10.1016/j.ijsu.2015.12.047. Epub 2015 Dec 21.

49.

Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease.

Bodini G, Giannini EG, Furnari M, Marabotto E, Baldissarro I, Del Nero L, Assandri L, Moscatelli A, Savarino V, Savarino E.

J Gastrointestin Liver Dis. 2015 Dec;24(4):451-6. doi: 10.15403/jgld.2014.1121.244.adb.

50.

Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD.

Martinucci I, Savarino EV, Pandolfino JE, Russo S, Bellini M, Tolone S, Tutuian R, Roman S, Furnari M, Frazzoni M, Macchia L, Savarino V, Marchi S, de Bortoli N.

Neurogastroenterol Motil. 2016 Feb;28(2):243-50. doi: 10.1111/nmo.12719. Epub 2015 Dec 11.

PMID:
26661383

Supplemental Content

Loading ...
Support Center